Serious reaction reminders: sodium valproate and fetal malformations
Serious reaction reminders: sodium valproate and fetal malformations
About this item
Full title
Journal title
Formats
Subjects
More information
Scope and Contents
Contents
Sodium valproate is well known to cause fetal malformations and is classified as a Pregnancy Category D drug. Teratogenic risk appears to be dose-dependent and increases markedly at doses greater than 1100 mg/day in the first trimester. (non-author abstract)
Alternative Titles
Full title
Serious reaction reminders: sodium valproate and fetal malformations
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_rmit_collectionsjats_10_3316_informit_561399458842463
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_rmit_collectionsjats_10_3316_informit_561399458842463
Other Identifiers
ISSN
0812-3837